![]() Biomatrica Biomatrica: The Biostability Company. We are the leaders at stabilizing biological samples and assays at ambient temperature. | ![]() Epigenomics Epigenomics AG isa molecular diagnostics company developing and manufacturinga pipeline of products for the diagnosis of cancer. | ![]() Indi Molecular Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. | |||
Founding Date | Founding Date 2004 | Founding Date 2006 | Founding Date 1998 | Founding Date 2013 | Founding Date 2010 |
Type | Type Subsidiary | Type Private | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations San Diego, US HQ | Locations Louisville, US HQ | Locations Berlin, DE HQ San Diego, US | Locations Culver City, US HQ | Locations Suwon, KR HQ Shanghai, CN Gurugram, IN Purwakarta, ID Cheongwon Gun, KR Gumi, KR Pyeongtaek, KR see more |
Employees | Employees 109% decrease | Employees 18,600 | Employees 329% decrease | Employees 30 | Employees 5952% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €24k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ₩710.6b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ₩347.9b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit €31k (FY, 2025) | Gross profit N/A | Gross profit ₩373.8b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income (€314k) (FY, 2025) | Net income N/A | Net income (₩513.4b) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 9.2m | Total funding raised N/A | Total funding raised $ 11.7m | Total funding raised $ 11.5m | Total funding raised N/A |

Pharmaron US is a provider of bioanalysis testing services.
View company
Epigenomics AG isa molecular diagnostics company developing and manufacturinga pipeline of products for the diagnosis of cancer.
View company
Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents.
View companySD Biosensor is an in-vitro diagnostic company.
View company